Dosimetry analysis based on ex vivo biodistribution data revealed distinct absorbed dose patterns for 177Lu-NM600 and 225Ac-NM600 across TRAMP-C1 and Myc-CaP tumor models. This evidence concerns the gene MYC and neoplasm.